Ascelia Pharma AB 

SEK2.97
1
+SEK0.08+2.77% Today

Statistics

Day High
3.01
Day Low
2.93
52W High
5.23
52W Low
2.31
Volume
120,629
Avg. Volume
814,432
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.19
0.03
0.26
0.49
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-80.03MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACE.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 clinical trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 clinical trial for the treatment of gastric cancer. The company has a collaboration agreement with the Taiho Oncology Inc. Ascelia Pharma AB (publ) was incorporated in 1999 and is headquartered in Malmö, Sweden.
Show more...
CEO
Mr. Magnus O. Corfitzen
Employees
11
Country
SE
ISIN
SE0010573113

Listings

0 Comments

Share your thoughts

FAQ

What is Ascelia Pharma AB stock price today?
The current price of ACE.ST is SEK2.97 SEK — it has increased by +2.77% in the past 24 hours. Watch Ascelia Pharma AB stock price performance more closely on the chart.
What is Ascelia Pharma AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ascelia Pharma AB stocks are traded under the ticker ACE.ST.
Is Ascelia Pharma AB stock price growing?
ACE.ST stock has risen by +0% compared to the previous week, the month change is a -4.31% fall, over the last year Ascelia Pharma AB has showed a +7.53% increase.
When is the next Ascelia Pharma AB earnings date?
Ascelia Pharma AB is going to release the next earnings report on May 14, 2026.
What is Ascelia Pharma AB revenue for the last year?
Ascelia Pharma AB revenue for the last year amounts to 0 SEK.
What is Ascelia Pharma AB net income for the last year?
ACE.ST net income for the last year is -80.03M SEK.
How many employees does Ascelia Pharma AB have?
As of April 01, 2026, the company has 11 employees.
In which sector is Ascelia Pharma AB located?
Ascelia Pharma AB operates in the Health Care sector.
When did Ascelia Pharma AB complete a stock split?
Ascelia Pharma AB has not had any recent stock splits.
Where is Ascelia Pharma AB headquartered?
Ascelia Pharma AB is headquartered in Malmö, SE.